# BGI Co-Win

> BGI Co-Win is a VC fund in Shenzhen backing Biotechnology and Health Care. See 16 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Shenzhen, China
- Total investments: 16
- Last investment: Feb 2025
- Lead investor: 25%
- Last updated: Aug 2026
- Website: http://www.bgi-cowin.com/

BGI Co-Win is a VC fund in Shenzhen focused on Biotechnology and Health Care. BGI Co-Win is the corporate venture capital arm of BGI and is based in Shenzhen, China.

## Contacts

5 contacts available for BGI Co-Win. Shizune tracks 2 team members at BGI Co-Win. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/bgi-co-win?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 11 | 69% |
| Health Care | 8 | 50% |
| Medical | 7 | 44% |
| Pharmaceutical | 7 | 44% |
| Medical Device | 4 | 25% |

12 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 5 | 31% |
| Series B | 4 | 25% |
| Seed | 2 | 13% |
| Series C | 2 | 13% |
| Angel | 1 | 6% |

7 stages tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Ji Changtao | Partner | 1 | https://shizune.co/investors/profile/ji-changtao |
| Liu Yu | Founding partner | 1 | https://shizune.co/investors/profile/yu-liu-d4d6 |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Aijie Boya | Aijie Boya is a medical instrument and magnetic solid-phase material company. | $13.7M |  | Feb 12, 2025 |  |
| LeadBio Tech | LeadBio Tech is a biotechnology company that specializes in the development of bioartificial blood vessel medical devices. | $13.7M | Series A | Nov 13, 2023 |  |
| Burning Point Medical | Burning Point Medical develops pharmaceutical products for hypertensive and spastic pain disorders. Burning Point's products aim to treat hypertension, and relieve chest pain and spastic pains, enabling healthcare professionals to prescribe more effective treatments to their patients. |  | Series B | Jun 16, 2023 |  |
| uBriGene | Ubrigene is driven by the advancement of gene and cell therapy technologies through research and development represented by AAV vectors. It can provide a comprehensive solution for gene therapy industrialization. | $14.7M | Series C | Dec 23, 2022 |  |
| Waker Biology | Weike Bio is a gene therapy drug development company. |  | Angel | Dec 20, 2022 |  |
| Yingshu Life | Yingshu Life is a research and development manufacturer of minimally invasive medical devices. |  | Seed | Nov 22, 2022 |  |
| Hemu Gene | Hemu Gene is a gene therapy technology developer. It has two gene editing platforms: lentivirus, CRISPR and Cas. | $4.4M | Series A | Aug 16, 2022 |  |
| YZY Bio | YZY Bio is a biotechnology company that develops anti-tumor bispecific antibodies based on breakthrough discoveries in molecular biology, enabling patients with major diseases to obtain more efficient treatment solutions. | $38.7M | Series B | Sep 13, 2021 |  |
| Realmind Biotech | Realmind Biotech develops Vitro diagnostic devices intended for medical assessments. From miniaturized chemiluminescence analyzer, to fully automatic chemiluminescence POCT, then to microdroplet chip POCT, till this day the company has laid out a comprehensive blueprint of multiple innovative IVD platforms. |  | Seed | Jul 19, 2021 |  |
| Ab&B Biotech | Ab&B Biotech focuses on the research and development of innovative human vaccines and multivalent vaccines. | $92.7M | Series C | Jul 16, 2021 |  |

10 of 16 investments shown.

## Co-investors
- [DT Capital Partners](https://shizune.co/investors/profile/dt-capital-partners) — VC Fund, 2 deals together
- [Green Pine Capital Partners](https://shizune.co/investors/profile/green-pine-capital-partners) — VC Fund, 2 deals together
- [Guohai Innovative CCI Capital](https://shizune.co/investors/profile/guohai-innovation-capital) — VC Fund, 2 deals together
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund, 2 deals together
- [Jinshi Investment](https://shizune.co/investors/profile/jinshi-investment) — VC Fund, 2 deals together
- [Sanhua Hongdao Investment](https://shizune.co/investors/profile/sanhua-hongdao-investment) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [Innova Memphis](https://shizune.co/investors/profile/innova-memphis) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund

## Featured in investor lists
- [Medical Device VC Funds in China](https://shizune.co/investors/medical-device-vc-funds-china)

## FAQ

### What does BGI Co-Win invest in?

BGI Co-Win invests primarily in Biotechnology, Health Care and Medical startups, most often at Series A and Series B stage. Most of the 16 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact BGI Co-Win?

Public channels for BGI Co-Win include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at BGI Co-Win?

The team at BGI Co-Win includes Ji Changtao (Partner) and Liu Yu (Founding partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co